Europe Human Leukocyte Antigens Hlas Typing Transplant Diagnostics Services Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 30.00 Million |
 Market Size (Forecast Year) |
USD 59.34 Million |
 CAGR |
% |
| Major Markets Players |
>欧洲人类白细胞抗原 (HLA) 分型移植诊断服务市场，按产品和服务（仪器、试剂和消耗品、软件和服务）、应用（诊断和研究）、最终用户（直接招标、医院药房、零售药房、网上药房和其他）、技术（聚合酶链反应和下一代测序）划分 - 行业趋势和预测到 2030 年。
欧洲人类白细胞抗原 (HLA) 分型移植诊断服务市场分析及规模
传染病的流行率不断上升、公共和私营部门对目标研究活动的资助不断增加以及实体器官和干细胞移植程序数量的增加是预测期内推动人类白细胞抗原 (HLA) 分型移植诊断服务市场增长的主要因素。此外，药物发现活动、移植程序以及组织工程、再生医学和肿瘤学研究应用数量的增加也促进了市场的整体增长。
Data Bridge Market Research 分析，人类白细胞抗原 (HLA) 分型移植诊断服务市场在 2022 年为 3000 万美元，预计到 2030 年将达到 5934 万美元，在 2023 年至 2030 年的预测期内复合年增长率为 8.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
欧洲人类白细胞抗原 (HLA) 分型移植诊断服务市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品与服务（仪器、试剂及耗材、软件及服务）、应用（诊断与研究）、终端用户（直接招标、医院药房、零售药房、网上药房及其他）、技术（聚合酶链反应和下一代测序） |
|
覆盖国家 |
德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区 |
|
涵盖的市场参与者 |
强生私人有限公司（美国）、西门子（德国）、BD（美国）、赛默飞世尔科技公司（美国）、QIAGEN（德国）、ProImmune Ltd.（英国）、Creative Biolabs（美国）、HistoGenetics LLC（美国）、加州大学洛杉矶分校医疗中心（美国）、美敦力（爱尔兰）、Takara Bio Inc.（日本）、Biofortuna Limited（英国）、Luminex Corporation（美国）、Hologic, Inc.（美国）、F. Hoffmann-La Roche Ltd.（瑞士）和 Bio-Rad Laboratories, Inc.（美国） |
|
Market Opportunities |
|
Market Definition
Human leukocyte antigens (HLAs) typing is a medical procedure used to determine patient and donor compatibility for cord blood or bone marrow transplants. Human leukocyte antigens (HLAs) are proteins in the body that are tested using DNA-based molecular diagnostic procedures.
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Dynamics
Drivers
- Increasing prevalence of infectious diseases
The increasing prevalence of infectious diseases, rising public-private funding for target research activities, and an increase in the number of solid organ and stem cell transplantation procedures are the major factors driving the growth of the human leukocyte antigens (HLAs) typing transplant diagnostics services market during the forecast period. Furthermore, the increasing number of drug discovery activities, transplant procedures, and applications in tissue engineering, regenerative medicine, and oncology research all contribute to the market's overall growth.
Opportunities
- Technological advancements
Technological advancements in HLA typing are a critical factor driving market growth. HLAs are highly polymorphic glycoproteins encoded by the major histocompatibility complex gene region (MHC). They have the biological function of presenting antigenic peptides to T lymphocytes. However, they play an important role in HSCT acceptance/rejection. Rising public-private funding for target research activities and an increase in the number of solid organ and stem cell transplantation procedures, among other factors driving the human leukocyte antigens (HLAs) typing transplant diagnostics services market. Furthermore, the increasing number of drug discovery activities and applications in tissue engineering, regenerative medicine, and oncology research will create new opportunities for the human leukocyte antigens (HLAs) typing transplant diagnostics services market between 2023 and 2030.
Restraints/Challenges
- High cost
Rising molecular testing costs will slow market growth. Furthermore, a lack of skilled medical professionals, a significant gap between the number of organ donors and organs, and a lack of a favourable reimbursement scenario in developing and underdeveloped economies will pose additional challenges to the market.
This human leukocyte antigens (HLAs) typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the human leukocyte antigens (HLAs) typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Scope
The human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Instruments
- Reagents and Consumables
- Software and Services
Application
- Diagnostics
- Research
End-User
- Direct Tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Technology
- Polymerase Chain Reaction
- Next-Generation Sequencing
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Regional Analysis/Insights
The human leukocyte antigens (HLAs) typing transplant diagnostics services market is analyzed and market size insights and trends are provided by country, product and services, application, end-user and technology as referenced above.
The countries covered in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
人类白细胞抗原 (HLA) 分型移植诊断服务市场还为您提供每个国家/地区资本设备医疗支出增长、人类白细胞抗原 (HLA) 分型移植诊断服务市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对人类白细胞抗原 (HLA) 分型移植诊断服务市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。
竞争格局和人类白细胞抗原 (HLA) 分型移植诊断服务市场份额分析
人类白细胞抗原 (HLA) 分型移植诊断服务市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对人类白细胞抗原 (HLA) 分型移植诊断服务市场的关注有关。
人类白细胞抗原 (HLA) 分型移植诊断服务市场的一些主要参与者包括：
- 强生私人有限公司（美国）
- 西门子（德国）
- BD（美国）
- Thermo Fischer Scientific. Inc.（美国）
- QIAGEN（德国）
- ProImmune Ltd.（英国）
- Creative Biolabs（美国）
- HistoGenetics LLC（美国）
- 加州大学洛杉矶分校健康中心（美国）
- 美敦力（爱尔兰）
- Takara Bio Inc.（日本）
- Biofortuna 有限公司 (英国)
- Luminex 公司（美国）
- Hologic, Inc.（美国）
- F. Hoffmann-La Roche Ltd.（瑞士）
- Bio-Rad Laboratories, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
